Related Experiment Video
Updated: Jun 27, 2025
04:53
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
761
Obstructive Sleep Apnea and Sarcoidosis Interactions.
1Pulmonary, Critical Care and Sleep Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, CSB 816, Msc 630, Charleston, SC 29425, USA.
Sleep Medicine Clinics
|May 1, 2024
Summary
Obstructive sleep apnea (OSA) is common in sarcoidosis patients due to upper airway issues and steroid side effects. Early OSA screening and treatment in sarcoidosis can significantly improve patient quality of life.
Area of Science:
- Pulmonology
- Sleep Medicine
- Rheumatology
Background:
- Obstructive sleep apnea (OSA) is highly prevalent in patients with sarcoidosis.
- Sarcoidosis can compromise upper airway patency through direct upper respiratory tract involvement.
- Factors like steroid-induced weight gain, myopathy, and interstitial lung disease contribute to OSA risk in sarcoidosis.
Purpose of the Study:
- To explore the high prevalence of obstructive sleep apnea (OSA) in sarcoidosis patients.
- To identify the contributing factors for increased OSA risk in sarcoidosis.
- To highlight the clinical overlap and importance of screening for OSA in sarcoidosis.
Main Methods:
- Review of existing literature on sarcoidosis and obstructive sleep apnea.
- Analysis of potential etiological links between sarcoidosis, its treatments, and OSA.
- Comparison of shared clinical manifestations between OSA and sarcoidosis.
Main Results:
- Sarcoidosis of the upper airway directly impacts upper airway patency, increasing OSA risk.
- Steroid therapy and sarcoidosis itself can lead to weight gain and myopathy, exacerbating OSA.
- Shared symptoms like fatigue, hypersomnolence, cognitive deficits, and pulmonary hypertension necessitate careful evaluation.
Conclusions:
- There is a significant and multifactorial link between sarcoidosis and obstructive sleep apnea.
- Early screening for OSA in sarcoidosis patients is crucial for managing shared symptoms.
- Timely diagnosis and treatment of OSA can improve outcomes and quality of life for sarcoidosis patients.
More Related Videos
Related Concept Videos
01:21Sleep Apnea
148
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
148
01:17Other Pulmonary Disorders
836
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
836
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
198
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
198
01:24Sleep-Wake Cycles
1.3K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.3K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K